Fig. 2From: Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcomaIdentification of OS-related targets and pathways. (A) 3579 OS-associated targets, the red round rectangle, and cyan-green round rectangles, respectively, represent OS and OS-associated targets. (B) The 10 representative terms with the lowest p value of BPs, MFs, and CCs GO enrichment (P < 0.05). (C) The 10 significantly enriched KEGG pathways of OS-associated targets (P < 0.05)Back to article page